Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure
NCT ID: NCT06815523
Last Updated: 2025-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1241 participants
OBSERVATIONAL
2025-02-02
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
NCT03145974
Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
NCT04791501
Prediction of Duration of Mechanical Ventilation in ARDS
NCT05993377
Intelligent Lung Support in the Intensive Care Unit
NCT06595602
Automatic Detection of Dyspnea in Mechanically Ventilated, Critically Ill Patients
NCT07205952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Derivation/testing cohort
The investigators will use a chort of 75% of patients, randomly selected, with data at T0, T24 and T48 after diagnosis of acute hypoxemic respiratory failure (AHRF). We will apply machine learning approaches.
Machine learning and logistic regression for the training/testing cohort and validation cohort
Machine learning and logistic regression for the validation cohort
Validation hohort
we will use 25% of unseen patients, randomly selected, with data at T0, T24 and T48 after diagnosis of AHRF.
Machine learning and logistic regression for the training/testing cohort and validation cohort
Machine learning and logistic regression for the validation cohort
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Machine learning and logistic regression for the training/testing cohort and validation cohort
Machine learning and logistic regression for the validation cohort
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PaO2/FiO2 ratio \<or = 300 mmHg under MV with PEEP \>or =5 and FiO2 \>or = 0.3
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Dr. NegrÃn (Las Palmas de Gran Canaria)
UNKNOWN
Iinstituto de Salud Carlos III
UNKNOWN
Jesus Villar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesus Villar
Scientific Advisor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesus Villar
Role: STUDY_DIRECTOR
Fundacion Canaria Instituto de Investigación Sanitaria de Canarias
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Dr. Negrin
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Universitario La Paz
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIFIISC24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.